港交所(00388.HK):密切觀察港府取消大部分豁免檢疫群組的影響
政府宣布計劃取消大部分豁免檢疫群組,或影響上市公司董事等商務人士來港。港交所(00388.HK)集團行政總裁歐冠昇表示,措施無可否認會有影響,指出疫情及防控措施為全球目前面對的主要挑戰,交易所正密切觀察事件,期望各方協調將影響降到最低,相信不會動搖香港金融中心地位。
歐冠昇又提到,滬港通及深港通成績理想,預期增長趨勢持續,但不會預測短期表現。聯交所就於香港推行「特殊目的收購公司」(SPAC)上市機制徵詢市場意見,諮詢期將於月底結束。他強調,希望在港推出的SPAC是高質量投資產品,將為投資者提供充分保護措施,評估市場意見後會盡快公布結果。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.